<p>Methods of treating disease with soluble inhibitors of the lymphotoxin pathway having improved properties. Improved LTBR-Ig fusion proteins, and pharmaceutical compositions thereof, are also described.</p>
申请公布号
EP2139509(A2)
申请公布日期
2010.01.06
申请号
EP20080742126
申请日期
2008.03.17
申请人
BIOGEN IDEC MA, INC.
发明人
FARRINGTON, GRAHAM, K.;BECKMAN, EVAN;BROWNING, JEFFREY, L.;MEIER, WERNER
